Spanish researchers have made an important step forward in the study of new treatment approaches for pancreatic cancer, one of the most aggressive and difficult-to-treat malignancies.
A scientific team has developed a combination therapy involving several drugs that, in preclinical studies, demonstrated the complete elimination of pancreatic tumors in experimental models. Notably, no tumor recurrence was observed after treatment, and side effects were minimal.
This therapeutic approach targets key molecular mechanisms responsible for tumor growth and resistance, including mutations considered central to the development of this type of cancer.
Although these results are currently limited to experimental (non-human) studies, they are regarded by the scientific community as highly promising and provide a strong foundation for future clinical trials.
This breakthrough opens new perspectives and offers hope for the development of more effective treatments in the future.
